Fusion tyrosine kinases: a result and cause of genomic instability

被引:60
作者
Penserga, E. T. P. [1 ]
Skorski, T. [1 ]
机构
[1] Temple Univ, Dept Microbiol & Immunol, Sch Med, Philadelphia, PA 19140 USA
关键词
fusion tyrosine kinase; genomic instability; ROS; DNA damage; DNA repair; imatinib mesylate;
D O I
10.1038/sj.onc.1209756
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reciprocal chromosomal translocations may arise as a result of unfaithful repair of spontaneous DNA double-strand breaks, most probably induced by oxidative stress, radiation, genotoxic chemicals and/or replication stress. Genes encoding tyrosine kinases are targeted by these mechanisms resulting in the generation of chimera genes encoding fusion tyrosine kinases (FTKs). FTKs display transforming activity owing to their constitutive kinase activity causing deregulated proliferation, apoptosis, differentiation and adhesion. Moreover, FTKs are able to facilitate DNA repair, prolong activation of G(2)/M and S cell cycle checkpoints, and elevate expression of antiapoptotic protein Bcl-X-L, making malignant cells less responsive to antitumor treatment. FTKs may also stimulate the generation of reactive oxygen species and enhance spontaneous DNA damage in tumor cells. Unfortunately, FTKs compromise the delity of DNA repair mechanisms, which contribute to the accumulation of additional genetic abnormalities leading to the resistance to inhibitors such as imatinib mesylate and malignant progression of the disease.
引用
收藏
页码:11 / 20
页数:10
相关论文
共 162 条
  • [1] Translocation and gross deletion breakpolints in human inherited disease and cancer I: Nucleotide composition and recomblination-assocliated motifs
    Abeysinghe, SS
    Chuzhanova, N
    Krawczak, M
    Ball, EV
    Cooper, DN
    [J]. HUMAN MUTATION, 2003, 22 (03) : 229 - 244
  • [2] Akman SA, 2000, ANN NY ACAD SCI, V899, P88
  • [3] THE KARYOTYPE OF BLASTIC CRISIS
    ALIMENA, G
    DECUIA, MR
    DIVERIO, D
    GASTALDI, R
    NANNI, M
    [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 26 (01) : 39 - 50
  • [4] Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3
    Amarante-Mendes, GP
    Kim, CN
    Liu, L
    Huang, Y
    Perkins, CL
    Green, DR
    Bhalla, K
    [J]. BLOOD, 1998, 91 (05) : 1700 - 1705
  • [5] CD30+lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis
    Aoki, M
    Niimi, Y
    Takezaki, S
    Azuma, A
    Seike, M
    Kawana, S
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2001, 145 (01) : 123 - 126
  • [6] Causes of oncogenic chromosomal translocation
    Aplan, PD
    [J]. TRENDS IN GENETICS, 2006, 22 (01) : 46 - 55
  • [7] Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
    Apperley, JF
    Gardembas, M
    Melo, JV
    Russell-Jones, R
    Bain, BJ
    Baxter, J
    Chase, A
    Chessells, JM
    Colombat, M
    Dearden, CE
    Dimitrijevic, S
    Mahon, FX
    Marin, D
    Nikolova, Z
    Olavarria, E
    Silberman, S
    Schultheis, B
    Cross, NCP
    Goldman, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 481 - 487
  • [8] Arlinghaus Ralph, 2004, Cancer Treat Res, V119, P239
  • [9] Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL
    Azam, M
    Latek, RR
    Daley, GQ
    [J]. CELL, 2003, 112 (06) : 831 - 843
  • [10] BARRETT A, 1992, BONE MARROW TRANSPL, V9, P305